Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for GKOS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2014. Start Trial.
Date Value
June 30, 2026 58.86M
March 31, 2026 58.36M
December 31, 2025 57.51M
September 30, 2025 57.39M
June 30, 2025 57.25M
March 31, 2025 56.74M
December 31, 2024 56.44M
September 30, 2024 55.09M
June 30, 2024 54.82M
March 31, 2024 49.85M
December 31, 2023 49.12M
September 30, 2023 48.72M
June 30, 2023 48.38M
March 31, 2023 47.94M
December 31, 2022 47.75M
September 30, 2022 47.66M
June 30, 2022 47.42M
March 31, 2022 47.09M
December 31, 2021 46.96M
September 30, 2021 46.86M
June 30, 2021 46.47M
March 31, 2021 45.99M
December 31, 2020 45.25M
September 30, 2020 44.83M
Date Value
June 30, 2020 44.55M
March 31, 2020 44.09M
December 31, 2019 43.50M
September 30, 2019 36.92M
June 30, 2019 36.64M
March 31, 2019 36.33M
December 31, 2018 36.11M
September 30, 2018 35.97M
June 30, 2018 35.14M
March 31, 2018 34.83M
December 31, 2017 34.62M
September 30, 2017 34.55M
June 30, 2017 34.43M
March 31, 2017 34.28M
December 31, 2016 33.94M
September 30, 2016 33.31M
June 30, 2016 32.92M
March 31, 2016 32.37M
December 31, 2015 32.18M
September 30, 2015 32.10M
June 30, 2015 31.95M
March 31, 2015 31.26M
March 31, 2014 31.26M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Globus Medical, Inc. 134.25M
Abbott Laboratories 1.730B
Alphatec Holdings, Inc. 152.68M
Artivion, Inc. 48.69M
ICU Medical, Inc. 25.01M